Sep 29, 2026
MOSANNA THERAPEUTICS REPORTS POSITIVE RESULTS FROM THE PHASE 1 MOSAIC STUDY OF MOS118 FOR OBSTRUCTIVE SLEEP APNEA
Read More
Aug 25, 2026
Basking Biosciences Announces Positive Topline Phase 1 Data for BB-025, the Reversal Agent for its Acute Ischemic Stroke Thrombolytic Therapy BB-031
Read More
Jul 28, 2026
Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687
Read More
Jul 28, 2026
HAYA Therapeutics Receives FDA Fast Track Designation for HTX-001
Read More
Jul 16, 2026
RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology
Read More
Jun 23, 2026
CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study
Read More
1234